Back in Q4 2024, US GDP grew at a strong 2.4% rate, however ... I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose ...

A patient participating in the Phase 2 pivotal trial of RP-A501 experienced an unexpected Serious Adverse Event (SAE). The SAE involved clinical complications related to a capillary leak syndrome.

Pump manufacturer AlfaOBL America — the North American division of Italy-based AlfaOBL — announced the opening of a new U.S. facility that enables 48-hour fulfillment on its core brand of products.